It’s not easy to get depression-detecting AI through the FDA

“Kintsugi, a seven-year-old startup developing AI to detect depression and anxiety from speech patterns, is closing due to inability to secure FDA clearance in time. The company is open-sourcing its technology, highlighting the significant regulatory hurdles AI health tools face and the challenges of commercializing medical AI applications.”